An interventional study of C. Santé software compared to polysomnography in Sleep Disorder (Disorder), sponsored by Centre Hospitalier Universitaire de Saint Etienne. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.
Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 65 studies in Sleep Wake Disorders with a site in France — 22 open to participants now, 27 under way, 4 of them phase 3. Sleep Wake Disorders · France.
Among the 65 studies in Sleep Wake Disorders with a site in France, this one is the 34th largest by planned enrollment of the 42 interventional ones that give a count, is one of 9 that started in 2026, is one of 29 with no phase, reaches primary completion later than 11 of the 26 other live ones, and was the 64th registered.
747 studies on the registry are indexed under Sleep Wake Disorders; 181 are open to participants now.
Browse Sleep Wake Disorders studies →22 of the 65 studies in Sleep Wake Disorders with a site in France are open now. Recruiting first, the newest first:
Replior AB · Sites in France
Ages 18–65
Direction Centrale du Service de Santé des Armées · Sites in France
Ages 18–65
Alkermes, Inc. · Sites in France, United States, Australia and 11 more countries
Ages 18–70
Alkermes, Inc. · Sites in France, United States, Australia and 12 more countries
Ages 18–70
University Hospital, Toulouse · Sites in France
Ages 18–65 · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 114 Sleep Wake Disorders studies recruiting now, 40 (35%) set no upper age limit and 53 (46%) stop at 75 or younger; 22 take children under 18; 28 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
65 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 6 · Phase 3 6 · Phase 4 2
First in 2009; this study’s year is marked. 9 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 33 is below the median of 66 across 531 interventional studies indexed under Sleep Wake Disorders.
Median enrollment 87 across the 42 interventional studies, 100 across the 23 observational. Of the 31 that completed or were terminated, 2 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 65 have an industry lead sponsor. The 10 most frequent:
Centre Hospitalier Universitaire de Saint Etienne is the lead sponsor of 598 studies on the registry; 128 are open to participants now.
Centre Hospitalier Universitaire de Saint Etienne has 2 studies filed under Sleep Wake Disorders — fewer than ten, so there is no comparison to draw.
14 of the studies in Sleep Wake Disorders with a site in France that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07502443Phase 3Alkermes, Inc.A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 | 2027-05 |
| NCT07455383Phase 3Alkermes, Inc.A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 | 2027-05 |
| NCT06843590Alkermes, Inc.A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia | 2026-11 |
| NCT07628959Centre Hospitalier Universitaire de Saint EtienneInnovative Sleep Quality Analysis Software Compared With Polysomnography | 2026-12 |
| NCT07909967Replior ABObservational Analytical Validation Study of the Replior ScratchSense | 2026-12-10 |
Add all 14 to your calendar (.ics) → With an account.
Among the 65 studies in Sleep Wake Disorders with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To diagnose sleep disorders, practitioners primarily use polysomnography (PSG), a precise but costly, cumbersome method that is limited to a single observation. This does not allow for longitudinal monitoring of sleep habits in real-world conditions. An alternative is offered with the C. Santé software receiving information from sensors installed on medical bed. This software analyzes cardiorespiratory parameters and sleep phases without disturbing the patient, enabling continuous and comfortable monitoring. A preliminary study aims to validate the reliability of the C. Santé software analysis, by comparing it to the PSG analysis, considered the gold standard.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The patients will spend two consecutive nights on the bed equipped with C. Santé software which is also equipped with traditional polysomnography.
Diagnostic Test: C. Santé software compared to polysomnography
Patients visit the Sleep Unit at the Clinique Mutualiste for sleep disorders. During their consultation with the doctor, a polysomnography scheduled over two consecutive nights is proposed (this applies to any diagnosis of sleep disorders). At that time, they are also invited to participate in the study. After receiving information about the study and signing the consent form, the patient returns for their two consecutive nights equipped with PSG, which they spend on the bed equipped with sensors transmitting information to C. Santé software.
The agreement in sleep efficiency measurement performed C. Santé software compared to polysomnography (PSG).
The study's objective will be met if the sleep efficiency measured by PSG and that calculated from C. Santé software differ by no more than 10%. This means the device will be considered effective if there is at least 90% agreement between PSG and the C. Santé software.
Time frame: "Up to 3 months after inclusion
Accuracy of RR interval measurement
Determined from the ECG trace of the PSG compared to the C. Santé software
Time frame: Up to 3 months after inclusion
Accuracy of sleep phase duration measurement
Comparing PSG-calculated durations for sleep stages (N1: light slowwave sleep, N2: intermediate slow-wave sleep, N3: deep slow-wave sleep, REM: rapid eye movement sleep) to the C. Santé software calculation for slow-wave sleep (N) and REM.
Time frame: Up to 3 months after inclusion
Accuracy of respiratory rate measurement
Comparing C. Santé software measurements to nasal cannula measurements from PSG (analyzed in 30-second intervals)
Time frame: Up to 3 months after inclusion
Accuracy in positional data
Comparing the time spent lying on the back or side and the number of position changes as calculated by PSG (via a thoracic accelerometer) and by C. Santé software.
Time frame: Up to 3 months after inclusion
Differences in measurements across two consecutive nights
Differences in measurements across two consecutive nights
Time frame: Up to 3 months after inclusion
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.
Of 214 non-industry interventional studies with no phase under Sleep Wake Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 40. This study's planned 2 months is below that.
Counting every sponsor, half of 249 studies reached it within 19 months; a quarter within 6 and three quarters within 37.
Start moved once since we started tracking on Sep 25, 2026: Jun 2026 → Oct 2026, on Oct 2, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de Saint Etienne →